Literature DB >> 21499211

Comparison between endoscopic ultrasound and magnetic resonance imaging for the staging of pancreatic cancer.

Vanessa M Shami1, Anshu Mahajan, Michelle M Loch, Alejandro C Stella, Patrick G Northup, Grace E White, Andrew S Brock, Indu Srinivasan, Eduard E de Lange, Michel Kahaleh.   

Abstract

OBJECTIVE: Preoperative staging of pancreatic cancer is crucial for proper therapy. Through this study, we aimed to compare the ability of endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI) to effectively detect and stage pancreatic cancer.
METHODS: One hundred twenty-seven patients undergoing EUS-fine-needle aspiration and MRI for the workup of pancreatic cancer were captured in a prospective database for comparison. The final surgical stage was recorded in patients who went to surgery.
RESULTS: Of 127 patients, 48 were surgically explored, and of these, 22 (46%) underwent pancreaticoduodenectomy. Agreement in the patients' staging between EUS and MRI was 94 (74%) of 127. Magnetic resonance imaging was more likely to report metastatic disease or arterial involvement. The overall correlation between EUS and MRI was marginal (κ = 0.42; 95% CI, 0.26-0.58). Of the 48 surgically explored patients, 12 (25%) were understaged by MRI, 13 (27%) were understaged by EUS, and 1 (2%) were overstaged. Endoscopic US and MRI had a sensitivity of 34 (97.2%) of 35 for stage II tumors and 35 (100%) of 35 for lower-stage tumors, respectively.
CONCLUSION: Endoscopic US and MRI had marginal correlation for staging, especially the more advanced tumors. Although EUS has the added advantage of tissue acquisition for confirmation, the tumors understaged by both the modalities were different. Therefore, both tests should be performed for accurate staging.

Entities:  

Mesh:

Year:  2011        PMID: 21499211     DOI: 10.1097/MPA.0b013e3182153b8c

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

1.  Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability.

Authors:  Vyacheslav I Egorov; Roman V Petrov; Elena N Solodinina; Gregory G Karmazanovsky; Natalia S Starostina; Natalia A Kuruschkina
Journal:  World J Gastrointest Surg       Date:  2013-04-27

Review 2.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

3.  Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis.

Authors:  Haq Nawaz; Chen Yi Fan; John Kloke; Asif Khalid; Kevin McGrath; Douglas Landsittel; Georgios I Papachristou
Journal:  JOP       Date:  2013-09-10

4.  Magnetization transfer MRI in pancreatic cancer xenograft models.

Authors:  Weiguo Li; Zhuoli Zhang; Jodi Nicolai; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

5.  Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.

Authors:  Jia Yang; Su Hu; Junjie Shangguan; Aydin Eresen; Yu Li; Liang Pan; Quanhong Ma; Yuri Velichko; Jian Wang; Chunhong Hu; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

Review 6.  Pancreatico-biliary endoscopic ultrasound: a systematic review of the levels of evidence, performance and outcomes.

Authors:  Pietro Fusaroli; Dimitrios Kypraios; Giancarlo Caletti; Mohamad A Eloubeidi
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

7.  Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging.

Authors:  Navid Farr; Yak-Nam Wang; Samantha D'Andrea; Kayla M Gravelle; Joo Ha Hwang; Donghoon Lee
Journal:  Cancer Med       Date:  2017-04-07       Impact factor: 4.452

8.  The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis.

Authors:  Paul D James; Zhao Wu Meng; Mei Zhang; Paul J Belletrutti; Rachid Mohamed; William Ghali; Derek J Roberts; Guillaume Martel; Steven J Heitman
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

9.  Evaluation of pancreatic tumor development in KPC mice using multi-parametric MRI.

Authors:  Ravneet Vohra; Joshua Park; Yak-Nam Wang; Kayla Gravelle; Stella Whang; Joo-Ha Hwang; Donghoon Lee
Journal:  Cancer Imaging       Date:  2018-11-08       Impact factor: 3.909

Review 10.  Endoscopic Ultrasound in the Diagnosis and Staging of Pancreatic Cancer.

Authors:  Bruno Gonçalves; João Bruno Soares; Pedro Bastos
Journal:  GE Port J Gastroenterol       Date:  2015-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.